Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.40 Down 0.00(0.47%) Jul 31, 3:54PM EDT
Add to Portfolio
Prev Close:0.40
Open:0.41
Bid:0.20 x 1400
Ask:0.41 x 100
1y Target Est:5.00
Beta:2.68
Earnings Date:Aug 12 - Aug 17 (Est.)
Day's Range:0.39 - 0.41
52wk Range:0.33 - 1.59
Volume:353,344
Avg Vol (3m):1,550,250
Market Cap:21.26M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 0.47%21.26M
SNYUp 0.78%141.18B
TEVADown 0.07%58.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.36
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback